-
1
-
-
33750430630
-
Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's A-42 peptide
-
Kim, W.; Hecht, M.H. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's A-42 peptide. Proc. Natl. Acad. Sci. U.S.A., 2006, 103, 15824-15829.
-
(2006)
Proc. Natl. Acad. Sci. U.S.A.
, vol.103
, pp. 15824-15829
-
-
Kim, W.1
Hecht, M.H.2
-
2
-
-
0042709605
-
Mechanisms of disease: Molecular mechanisms of amyloidosis
-
Merlini, G.; Bellotti, V. Mechanisms of disease: molecular mechanisms of amyloidosis. New England J. Med., 2003, 349, 519-521.
-
(2003)
New England J. Med.
, vol.349
, pp. 519-521
-
-
Merlini, G.1
Bellotti, V.2
-
3
-
-
36749062430
-
Molecular and cellular mechanisms for Alzheimer's disease: Understanding APP metabolism
-
Zhang, Y.W.; Xu, H. Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism. Curr. Mol. Med., 2007, 7, 687-696.
-
(2007)
Curr. Mol. Med.
, vol.7
, pp. 687-696
-
-
Zhang, Y.W.1
Xu, H.2
-
4
-
-
80053589341
-
Membrane and surface interactions of Alzheimer's A- peptide-insights into the mechanism of cytotoxicity
-
Williams, T.L.; Serpell, L.C. Membrane and surface interactions of Alzheimer's A- peptide-insights into the mechanism of cytotoxicity. FEBS J., 2011, 278, 3905-17.
-
(2011)
FEBS J.
, vol.278
, pp. 3905-3917
-
-
Williams, T.L.1
Serpell, L.C.2
-
5
-
-
34548555711
-
Genetics of Alzheimer's disease: A rapidly evolving field
-
Serretti, A.; Olgiati, P.; De Ronchi, D. Genetics of Alzheimer's disease: a rapidly evolving field. J. Alz. Dis., 2007, 12, 73-92.
-
(2007)
J. Alz. Dis.
, vol.12
, pp. 73-92
-
-
Serretti, A.1
Olgiati, P.2
De Ronchi, D.3
-
6
-
-
34447316702
-
Genetics of Alzheimer's disease: A centennial review
-
Ertekin-Taner, N. Genetics of Alzheimer's disease: a centennial review. Neurol. Clin., 2007, 25, 611-667.
-
(2007)
Neurol. Clin.
, vol.25
, pp. 611-667
-
-
Ertekin-Taner, N.1
-
7
-
-
0030786120
-
Small heat shock proteins inhibit in vitro A- 1-42 amyloidogenesis
-
Kudva, Y.C.; Hiddinga, H.J.; Butler, P.C.; Mueske, C.S.; Eberhardt, N.L. Small heat shock proteins inhibit in vitro A- 1-42 amyloidogenesis. FEBS Lett., 1997, 416, 117-121.
-
(1997)
FEBS Lett.
, vol.416
, pp. 117-121
-
-
Kudva, Y.C.1
Hiddinga, H.J.2
Butler, P.C.3
Mueske, C.S.4
Eberhardt, N.L.5
-
8
-
-
0035877756
-
Pearson J Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein
-
Chishti, M.A.; Yang, D.S.; Janus, C.; Phinney, A.L.; Horn, P. Pearson J Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein. J. Biol. Chem., 2001, 276, 21562-21570.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 21562-21570
-
-
Chishti, M.A.1
Yang, D.S.2
Janus, C.3
Phinney, A.L.4
Horn, P.5
-
9
-
-
0012510759
-
Amyloid plaque core protein in Alzheimer disease and Down syndrome
-
Masters, C.L.; Simms, G.; Weinman, N.A.; Multhaup, G.; McDonald, B.L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A., 1985, 82, 4245-4249.
-
(1985)
Proc. Natl. Acad. Sci. U.S.A.
, vol.82
, pp. 4245-4249
-
-
Masters, C.L.1
Simms, G.2
Weinman, N.A.3
Multhaup, G.4
McDonald, B.L.5
Beyreuther, K.6
-
10
-
-
0028172886
-
8-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red
-
Lorenzo, A.; Yankner, B.A. 8-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A., 1994, 91, 12243-12247.
-
(1994)
Proc. Natl. Acad. Sci. U.S.A.
, vol.91
, pp. 12243-12247
-
-
Lorenzo, A.1
Yankner, B.A.2
-
11
-
-
0037174618
-
Alzheimer's disease is a synaptic failure
-
Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science, 2002, 298, 789-791.
-
(2002)
Science
, vol.298
, pp. 789-791
-
-
Selkoe, D.J.1
-
12
-
-
80955166037
-
Defective protein folding and aggregation as the basis neurodegenerative disease: The darker aspect of proteins
-
Naeem, A.; Fazili, N.A. Defective protein folding and aggregation as the basis neurodegenerative disease: the darker aspect of proteins. Cell. Biochem. Biophys., 2011, 61, 237-250.
-
(2011)
Cell. Biochem. Biophys.
, vol.61
, pp. 237-250
-
-
Naeem, A.1
Fazili, N.A.2
-
13
-
-
0032006678
-
Alternative conformation of amyloidogenic proteins and their multi-step assembly pathways
-
Kelly, J. Alternative conformation of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol., 1998, 8, 101-106.
-
(1998)
Curr. Opin. Struct. Biol.
, vol.8
, pp. 101-106
-
-
Kelly, J.1
-
14
-
-
0035961329
-
The structural basis of protein folding and its links with human disease
-
Dobson, C.M. The structural basis of protein folding and its links with human disease. Philos. T. Roy. Soc. B, 2001, 356, 133-145.
-
(2001)
Philos. T. Roy. Soc. B
, vol.356
, pp. 133-145
-
-
Dobson, C.M.1
-
15
-
-
0031056829
-
Instability unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
-
Booth, D, R.; Sunde, M.; Bellotti, V.; Robinson. C.V.; Hutchinson, W.L.; Fraser, P.E.; Hawkins, P.N.; Dobson, C.M.; Radford, S.E.; Blake, C.F.; Pepys, M.B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature, 1997, 385, 787-793.
-
(1997)
Nature
, vol.385
, pp. 787-793
-
-
Booth, D.R.1
Sunde, M.2
Bellotti, V.3
Robinson, C.V.4
Hutchinson, W.L.5
Fraser, P.E.6
Hawkins, P.N.7
Dobson, C.M.8
Radford, S.E.9
Blake, C.F.10
Pepys, M.B.11
-
16
-
-
0028856292
-
Defective protein folding as a basis of human disease
-
Thomas, P.J.; Qu, B.H.; Pedersen, P.L. Defective protein folding as a basis of human disease. Trends Biochem. Sci., 1995, 20, 456-459.
-
(1995)
Trends Biochem. Sci.
, vol.20
, pp. 456-459
-
-
Thomas, P.J.1
Qu, B.H.2
Pedersen, P.L.3
-
17
-
-
0035920156
-
Tetramer dissociation and monomer partial unfolding precedes protofibril formation amyloidogenic transthyretin variants
-
Quintas, A.; Vaz, D.C.; Cardoso, I.; Saraiva, M.J.M.; Brito, R.M.M. Tetramer dissociation and monomer partial unfolding precedes protofibril formation amyloidogenic transthyretin variants. J. Biol. Chem., 2001, 276, 27207-27213.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 27207-27213
-
-
Quintas, A.1
Vaz, D.C.2
Cardoso, I.3
Saraiva, M.J.M.4
Brito, R.M.M.5
-
18
-
-
0031435479
-
The molecular basis of amyloidosis
-
Serpell, L.C.; Sunde, M.; Blake, C.C.F. The molecular basis of amyloidosis. Cell. Mol. Life Sci., 1997, 53, 871-887.
-
(1997)
Cell. Mol. Life Sci.
, vol.53
, pp. 871-887
-
-
Serpell, L.C.1
Sunde, M.2
Blake, C.C.F.3
-
19
-
-
2342569618
-
Conformational constraints for amyloid fibrillation: The importance of being unfolded
-
Uversky, V.N.; Fink, A.L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta, 2004, 1698, 131-153.
-
(2004)
Biochim. Biophys. Acta
, vol.1698
, pp. 131-153
-
-
Uversky, V.N.1
Fink, A.L.2
-
20
-
-
0141861067
-
Protein folding revisited. A polypeptide chain at the folding- misfolding- nonfolding cross-roads: Which way to go?
-
Uversky, V.N. Protein folding revisited. A polypeptide chain at the folding- misfolding- nonfolding cross-roads: which way to go? Cell. Mol. Life Sci., 2003, 60, 1852-1871.
-
(2003)
Cell. Mol. Life Sci.
, vol.60
, pp. 1852-1871
-
-
Uversky, V.N.1
-
21
-
-
0035918288
-
Prediction of amyloid fibril-forming proteins
-
Kallberg, Y.; Gustafsson. M.; Persson, B.; Thyberg, J.; Johansson, J. Prediction of amyloid fibril-forming proteins. J. Biol. Chem., 2001, 276, 12945-12950.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 12945-12950
-
-
Kallberg, Y.1
Gustafsson, M.2
Persson, B.3
Thyberg, J.4
Johansson, J.5
-
22
-
-
18844434395
-
Understanding the relationship between the primary structure of proteins and their amyloidogenic propensity: Clues from inclusion body formation
-
Thomas, S, I.; Balaji, P.V. Understanding the relationship between the primary structure of proteins and their amyloidogenic propensity: clues from inclusion body formation. Protein Eng. Des. Sel., 2005, 18, 175-180.
-
(2005)
Protein Eng. Des. Sel.
, vol.18
, pp. 175-180
-
-
Thomas, S.I.1
Balaji, P.V.2
-
23
-
-
0031932169
-
Protein aggregation: Folding aggregates, inclusion bodies and amyloid
-
Fink, A.L. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des., 1998, 3, R9-R23.
-
(1998)
Fold Des.
, vol.3
, pp. R9-R23
-
-
Fink, A.L.1
-
24
-
-
1642417648
-
Amyloid fibrils from the viewpoint of protein folding
-
Ohnishi, S.; Takano, K. Amyloid fibrils from the viewpoint of protein folding. Cell. Mol. Life Sci., 2004, 61, 511-524.
-
(2004)
Cell. Mol. Life Sci.
, vol.61
, pp. 511-524
-
-
Ohnishi, S.1
Takano, K.2
-
25
-
-
70349322482
-
Protein aggregation: More than just fibrils
-
Krebs, M.R.H.; Domike, K.R.; Donald, A.M. Protein aggregation: more than just fibrils. Biochem. Soc. T., 2009, 37, 682-686.
-
(2009)
Biochem. Soc. T.
, vol.37
, pp. 682-686
-
-
Krebs, M.R.H.1
Domike, K.R.2
Donald, A.M.3
-
26
-
-
33846839238
-
Protein particulates: Another generic form of protein aggregation
-
Krebs, M.R.H.; Devlin, G.L.; Donald, A.M. Protein particulates: another generic form of protein aggregation. Biophys. J., 2007, 92, 1336-1342.
-
(2007)
Biophys. J.
, vol.92
, pp. 1336-1342
-
-
Krebs, M.R.H.1
Devlin, G.L.2
Donald, A.M.3
-
27
-
-
38049062509
-
Thermal dependence of thermally induced protein spherulite formation and growth: Kinetics of - Lactoglobulin and insulin
-
Domike, K.R.; Donald, A.M. Thermal dependence of thermally induced protein spherulite formation and growth: kinetics of - lactoglobulin and insulin. Biomacromolecules, 2007, 8, 3930-3937.
-
(2007)
Biomacromolecules
, vol.8
, pp. 3930-3937
-
-
Domike, K.R.1
Donald, A.M.2
-
28
-
-
21244471488
-
Amyloid: Toward terminology clarification from the Nomenclature Committee of the International Society of Amyloidosis
-
Westermark, P.; Benson, M.D.; Buxbaum, J.N.; Cohen, A.S.; Frangione, B.; Ikeda, S.; Masters, C.L.; Merlini, G.; Saraiva, M.J.; Sipe, J.D. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid, 2005, 12, 1-4.
-
(2005)
Amyloid
, vol.12
, pp. 1-4
-
-
Westermark, P.1
Benson, M.D.2
Buxbaum, J.N.3
Cohen, A.S.4
Frangione, B.5
Ikeda, S.6
Masters, C.L.7
Merlini, G.8
Saraiva, M.J.9
Sipe, J.D.10
-
29
-
-
0030801746
-
The structure of amyloid fibrils by electron microscopy and X- ray diffraction
-
Sunde, M.; Blake C.C.F. The structure of amyloid fibrils by electron microscopy and X- ray diffraction. Adv. Protein Chem., 1997, 50, 123-159.
-
(1997)
Adv. Protein Chem.
, vol.50
, pp. 123-159
-
-
Sunde, M.1
Blake, C.C.F.2
-
30
-
-
0033200063
-
Protein misfolding, evolution and disease
-
Dobson, C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci., 1999, 24, 329-332.
-
(1999)
Trends Biochem. Sci.
, vol.24
, pp. 329-332
-
-
Dobson, C.M.1
-
31
-
-
0033977086
-
Amyloid fibrillogenesis: Themes and variations
-
Rochet, J.C.; Lansbury, P. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol., 2000, 10, 60-68.
-
(2000)
Curr. Opin. Struct. Biol.
, vol.10
, pp. 60-68
-
-
Rochet, J.C.1
Lansbury, P.2
-
32
-
-
0034725535
-
The protofilament substructure of amyloid fibrils
-
Serpell, L.C.; Sunde, M.; Benson, M.D.; Tennent, G.A.; Pepys, M.B.; Fraser, P. E. The protofilament substructure of amyloid fibrils. J. Mol. Biol., 2000, 300, 1033-1039.
-
(2000)
J. Mol. Biol.
, vol.300
, pp. 1033-1039
-
-
Serpell, L.C.1
Sunde, M.2
Benson, M.D.3
Tennent, G.A.4
Pepys, M.B.5
Fraser, P.E.6
-
33
-
-
33750480868
-
Characterization of the nanoscale properties of individual amyloid fibrils
-
Smith, J.F.; Tuomas, J.F.; Knowles, P.J.; Dobson, C.M.; Mac Phee, C.E.; Welland, M.E. Characterization of the nanoscale properties of individual amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A., 2006, 24, 15806-15811.
-
(2006)
Proc. Natl. Acad. Sci. U.S.A.
, vol.24
, pp. 15806-15811
-
-
Smith, J.F.1
Tuomas, J.F.2
Knowles, P.J.3
Dobson, C.M.4
Mac Phee, C.E.5
Welland, M.E.6
-
34
-
-
77949830350
-
The Alzheimer's disease-associated amyloidβ Protein is an antimicrobial peptide
-
Soscia, S.J.; Kirby, J.E.; Washicosky, K.J.; Tucker, S.M.; Ingelsson, M.; Hyman, B.; Burton, M.A.; Goldstein, L.E.; Duong, S.; Tanzi, R.E.; Moir, R.D. The Alzheimer's disease-associated amyloidβ Protein is an antimicrobial peptide. PLos One, 2010, 5, 1-10.
-
(2010)
PLos One
, vol.5
, pp. 1-10
-
-
Soscia, S.J.1
Kirby, J.E.2
Washicosky, K.J.3
Tucker, S.M.4
Ingelsson, M.5
Hyman, B.6
Burton, M.A.7
Goldstein, L.E.8
Duong, S.9
Tanzi, R.E.10
Moir, R.D.11
-
36
-
-
78650459964
-
Long-term post-operative cognitive decline in the elderly: The effects of anesthesia type, apolipoprotein e genotype, and clinical antecedents
-
Ancelina, M.L.; de Roquefeuila, G.; Scalia, J.; Bonnel, F.; Adam, J.F.; Cheminal, J.C.; Cristold, J.P.; Anne-Marie Dupuya, A.M.; Carriere, I.; Karen Ritchiea, K. Long-Term Post-Operative Cognitive Decline in the Elderly: The Effects of Anesthesia Type, Apolipoprotein E Genotype, and Clinical Antecedents. J. Alzheimer Dis., 2010, 22, S105-S113.
-
(2010)
J. Alzheimer Dis.
, vol.22
, pp. S105-S113
-
-
Ancelina, M.L.1
De Roquefeuila, G.2
Scalia, J.3
Bonnel, F.4
Adam, J.F.5
Cheminal, J.C.6
Cristold, J.P.7
Anne-Marie Dupuya, A.M.8
Carriere, I.9
Karen Ritchiea, K.10
-
37
-
-
84887574873
-
Soluble amyloidβ - Precursor protein binds its cell surface receptor in a cooperative fashion with glypican and syndecan proteoglycans
-
Reinhard, C.; Borgers, M.; David, G.; Strooper, B.D. Soluble amyloidβ - precursor protein binds its cell surface receptor in a cooperative fashion with glypican and syndecan proteoglycans. J. Cell Sci., 2013, (doi: 10.1242/jcs.137919)
-
(2013)
J. Cell Sci.
-
-
Reinhard, C.1
Borgers, M.2
David, G.3
Strooper, B.D.4
-
38
-
-
84889260626
-
Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloidβ - Secretion via deregulated lysosomal exocytosis
-
Annunziata, I.; Annette Patterson, A.; Helton, D.; Hu, H.; Moshiach, S.; Gomero, E.; Ralph Nixon, R.; d'Azzo, A. Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloidβ - secretion via deregulated lysosomal exocytosis. Nat. Commun., 2013, 4(2734), (doi:10.1038/ncomms3734)
-
(2013)
Nat. Commun.
, vol.4
, Issue.2734
-
-
Annunziata, I.1
Annette Patterson, A.2
Helton, D.3
Hu, H.4
Moshiach, S.5
Gomero, E.6
Ralph Nixon, R.7
D'Azzo, A.8
-
39
-
-
84886311163
-
Genetic and genomic aspects of Alzheimer's disease
-
Sze-Ming Chua, S.M.; Beng-Yeong Ng, B.Y.; Tih-Shih Lee, T.S. Genetic and Genomic Aspects of Alzheimer's Disease. Proceedings of Singapore Healthcare, 2010, 19(4), 334-341.
-
(2010)
Proceedings of Singapore Healthcare
, vol.19
, Issue.4
, pp. 334-341
-
-
Sze-Ming Chua, S.M.1
Beng-Yeong Ng, B.Y.2
Tih-Shih Lee, T.S.3
-
40
-
-
0025879957
-
An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance
-
Kowall, N.W.; Beal, M.F.; Busciglio, J.; Duffy, L.K.; Yankner, B.A. An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance. Proc. Natl. Acad. Sci. U.S.A., 1991, 88, 7247-7251.
-
(1991)
Proc. Natl. Acad. Sci. U.S.A.
, vol.88
, pp. 7247-7251
-
-
Kowall, N.W.1
Beal, M.F.2
Busciglio, J.3
Duffy, L.K.4
Yankner, B.A.5
-
41
-
-
0025733411
-
Aggregation- related toxicity of synthetic β-amyloid protein in hippocampal cultures
-
Pike, C.J.; Walencewicz, A.J.; Glabe, C.G.; Cotman, C.W. Aggregation- related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur. J. Pharmacol., 1991, 207, 367-368.
-
(1991)
Eur. J. Pharmacol.
, vol.207
, pp. 367-368
-
-
Pike, C.J.1
Walencewicz, A.J.2
Glabe, C.G.3
Cotman, C.W.4
-
42
-
-
2542424288
-
Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease
-
Wakutani, Y.; Watanabe, K.; Adachi, Y.; Wada-Isoe, K.; Urakami, K.; Ninomiya, H.; Saido, T.C.; Hashimoto, T.; Iwatsubo, T.; Nakashima, K. Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease. J. Neurol. Neurosurg. Psych., 2004, 75, 1039-1042.
-
(2004)
J. Neurol. Neurosurg. Psych.
, vol.75
, pp. 1039-1042
-
-
Wakutani, Y.1
Watanabe, K.2
Adachi, Y.3
Wada-Isoe, K.4
Urakami, K.5
Ninomiya, H.6
Saido, T.C.7
Hashimoto, T.8
Iwatsubo, T.9
Nakashima, K.10
-
43
-
-
84860434786
-
Amyloidβbeta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies
-
Chen, W.T.; Hong, C, J.; Lin, Y.T.; Chang, W.H.; Huang, H.T.; Liao, J, Y.; Chang, Y.J.; Hsieh, Y.F.; Cheng, C.; Liu, H.C.; Chen, Y.R.; Cheng, I, H, Amyloidβbeta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies. PLoS One, 2012, 7, e35807.
-
(2012)
PLoS One
, vol.7
, pp. e35807
-
-
Chen, W.T.1
Hong, C.J.2
Lin, Y.T.3
Chang, W.H.4
Huang, H.T.5
Liao, J.Y.6
Chang, Y.J.7
Hsieh, Y.F.8
Cheng, C.9
Liu, H.C.10
Chen, Y.R.11
Cheng, I.H.12
-
44
-
-
9844261165
-
A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of Aβ42
-
Eckman, C.B.; Mehta, N.D.; Crook, R.; Perez-tur, J.; Prihar, G.; Pfeiffer, E.; Radford, N.G.; Hinder, P.; Yager, D.; Zenk, B.; Refolo, L.M.; Prada, C.M.; Younkin, S.G.; Hutton, M.; Hardy, J. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of Aβ42. Hum. Mol. Genet., 1997, 6, 2087-2089.
-
(1997)
Hum. Mol. Genet.
, vol.6
, pp. 2087-2089
-
-
Eckman, C.B.1
Mehta, N.D.2
Crook, R.3
Perez-Tur, J.4
Prihar, G.5
Pfeiffer, E.6
Radford, N.G.7
Hinder, P.8
Yager, D.9
Zenk, B.10
Refolo, L.M.11
Prada, C.M.12
Younkin, S.G.13
Hutton, M.14
Hardy, J.15
-
45
-
-
34247516510
-
The arctic Alzheimer mutation favors intracellular amyloid β production by making amyloid precursor protein less available to α-secretase
-
Sahlin, C.; Lord, A.; Magnusson, K.; Englund, H.; Almeida, C.G.; Greengard, P.; Nyberg, F.; Gouras, G.K.; Lannfelt, L.; Nilsson, L.N.G. The arctic Alzheimer mutation favors intracellular amyloid β production by making amyloid precursor protein less available to α-secretase. J. Neurochem., 2007, 101, 854-862.
-
(2007)
J. Neurochem.
, vol.101
, pp. 854-862
-
-
Sahlin, C.1
Lord, A.2
Magnusson, K.3
Englund, H.4
Almeida, C.G.5
Greengard, P.6
Nyberg, F.7
Gouras, G.K.8
Lannfelt, L.9
Nilsson, L.N.G.10
-
46
-
-
0026597063
-
Alzheimer's disease: The amyloid cascade hypothesis
-
Hardy, J.A.; Higgins, G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science, 1992, 256, 184-185.
-
(1992)
Science
, vol.256
, pp. 184-185
-
-
Hardy, J.A.1
Higgins, G.A.2
-
47
-
-
0037135111
-
The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
-
Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002, 297, 353-356.
-
(2002)
Science
, vol.297
, pp. 353-356
-
-
Hardy, J.1
Selkoe, D.J.2
-
48
-
-
49149112780
-
Beta-amyloid protein aggregation
-
Etienne, M.A.; Edwin, N.J.; Aucoin JP, Russo PS, McCarley RL, Hammer RP. Beta-amyloid protein aggregation. Methods Mol. Biol., 2007, 386, 203-225.
-
(2007)
Methods Mol. Biol.
, vol.386
, pp. 203-225
-
-
Etienne, M.A.1
Edwin, N.J.2
Aucoin, J.P.3
Russo, P.S.4
McCarley, R.L.5
Hammer, R.P.6
-
49
-
-
1542364225
-
Curcumin has potent anti- amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro
-
Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Curcumin has potent anti- amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro. J. Neurosci. Res., 2004, 75, 742-750.
-
(2004)
J. Neurosci. Res.
, vol.75
, pp. 742-750
-
-
Ono, K.1
Hasegawa, K.2
Naiki, H.3
Yamada, M.4
-
50
-
-
20044370990
-
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo
-
Yang, F.; Lim, G.P.; Begum, A.N.; Ubeda, O.J.; Simmons, M.R.; Ambegaokar, S.S.; Chen, P.P.; Kayed, R.; Glabe, C.G.; Frautschy, S.A.; Cole, G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo. J. Biol. Chem., 2005, 280, 5892-5901.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 5892-5901
-
-
Yang, F.1
Lim, G.P.2
Begum, A.N.3
Ubeda, O.J.4
Simmons, M.R.5
Ambegaokar, S.S.6
Chen, P.P.7
Kayed, R.8
Glabe, C.G.9
Frautschy, S.A.10
Cole, G.M.11
-
51
-
-
34548182307
-
Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility
-
Reinke, A.A.; Gestwicki, J.E. Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem. Biol. Drug Des., 2007, 70, 206-215.
-
(2007)
Chem. Biol. Drug Des.
, vol.70
, pp. 206-215
-
-
Reinke, A.A.1
Gestwicki, J.E.2
-
52
-
-
48649094823
-
Plant-derived polyphenols attenuate lipopolysaccharide-induced nitric oxide and tumour necrosis factor production in murine microglia and macrophages
-
Shanmugam, K.; Holmquist, L.; Steele, M.; Stuchbury, G.; Berbaum, K.; Schulz, O.; Garcia, B.O.; Castillo, J.; Burnell, J.; Rivas, G.V.; Dobson, G.; Munch, G. Plant-derived polyphenols attenuate lipopolysaccharide-induced nitric oxide and tumour necrosis factor production in murine microglia and macrophages. Mol. Nutr. Food Res., 2008, 52, 427-438.
-
(2008)
Mol. Nutr. Food Res.
, vol.52
, pp. 427-438
-
-
Shanmugam, K.1
Holmquist, L.2
Steele, M.3
Stuchbury, G.4
Berbaum, K.5
Schulz, O.6
Garcia, B.O.7
Castillo, J.8
Burnell, J.9
Rivas, G.V.10
Dobson, G.11
Munch, G.12
-
53
-
-
79951581293
-
Silibinin: A novel inhibitor of Aβ aggregation
-
Yin, F.; Liu, J.; Ji, X.; Wang, Y.; Zidichouski, J.; Zhang, J. Silibinin: a novel inhibitor of Aβ aggregation. Neurochem. Int., 2011, 58, 399-403.
-
(2011)
Neurochem. Int.
, vol.58
, pp. 399-403
-
-
Yin, F.1
Liu, J.2
Ji, X.3
Wang, Y.4
Zidichouski, J.5
Zhang, J.6
-
54
-
-
0029863551
-
Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger
-
Tomiyama, T.; Shoji, A.; Kataoka, K.; Suwa, Y.; Asano, S.; Kaneko, H.; Endo, N. Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem., 1996, 271, 6839-6844.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 6839-6844
-
-
Tomiyama, T.1
Shoji, A.2
Kataoka, K.3
Suwa, Y.4
Asano, S.5
Kaneko, H.6
Endo, N.7
-
55
-
-
0027168310
-
Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats
-
Mindermann, T.; Landolt, H.; Zimmerli, W.; Rajacic, Z.; Gratzl, O. Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats. J. Antimicrob. Chemother., 1993, 31, 731-737.
-
(1993)
J. Antimicrob. Chemother.
, vol.31
, pp. 731-737
-
-
Mindermann, T.1
Landolt, H.2
Zimmerli, W.3
Rajacic, Z.4
Gratzl, O.5
-
56
-
-
33646595648
-
NAP: Research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP)
-
Gozes, I.; Morimoto, B.H.; Tiong, J.; Fox, A.; Sutherland, K.; Dangoor, D.; Holser- Cochav, M.; Vered, K.; Newton, P.; Aisen, P.S.; Matsuoka, Y.; van Dyck, C.H.; Thal, L. NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). CNS Drug Rev., 2005, 11, 353-368.
-
(2005)
CNS Drug Rev.
, vol.11
, pp. 353-368
-
-
Gozes, I.1
Morimoto, B.H.2
Tiong, J.3
Fox, A.4
Sutherland, K.5
Dangoor, D.6
Holser- Cochav, M.7
Vered, K.8
Newton, P.9
Aisen, P.S.10
Matsuoka, Y.11
Van Dyck, C.H.12
Thal, L.13
-
57
-
-
0347990378
-
The neuroprotective peptide NAP inhibits the aggregation of the β-amyloid peptide
-
Fabian, O.A.; Ruder, Y.S.; Skutelsky, E.; Brenneman, D.E.; Steingart, R.A.; Giladi, E.; Gozes, I. The neuroprotective peptide NAP inhibits the aggregation of the β-amyloid peptide. Peptides, 2003, 24, 1413-1423.
-
(2003)
Peptides
, vol.24
, pp. 1413-1423
-
-
Fabian, O.A.1
Ruder, Y.S.2
Skutelsky, E.3
Brenneman, D.E.4
Steingart, R.A.5
Giladi, E.6
Gozes, I.7
-
58
-
-
63449099645
-
Fibril aggregation inhibitory activity of the β-sheet breaker peptides: A molecular docking approach
-
Chini, M.G.; Scrima, M.; D'Ursi, A.M.; Bifulco, G. Fibril aggregation inhibitory activity of the β-sheet breaker peptides: a molecular docking approach. J. Pept. Sci., 2009, 15, 229-234.
-
(2009)
J. Pept. Sci.
, vol.15
, pp. 229-234
-
-
Chini, M.G.1
Scrima, M.2
D'Ursi, A.M.3
Bifulco, G.4
-
59
-
-
42449111198
-
Stabilization of a β-hairpin in monomeric Alzheimer's amyloidβ peptide inhibits amyloid formation
-
Hoyer, W.; Gronwall, W.; Jonsson, A.; Stahl, S.; Hard, T. Stabilization of a β-hairpin in monomeric Alzheimer's amyloidβ peptide inhibits amyloid formation. Proc. Natl. Acad. Sci. U.S.A., 2008, 105, 5099-5104.
-
(2008)
Proc. Natl. Acad. Sci. U.S.A.
, vol.105
, pp. 5099-5104
-
-
Hoyer, W.1
Gronwall, W.2
Jonsson, A.3
Stahl, S.4
Hard, T.5
-
60
-
-
0033815406
-
Review of the acetylcholinesterase inhibitor galantamine
-
Sramek, J.J.; Frackiewicz, E.J.; Cutler, N.R. Review of the acetylcholinesterase inhibitor galantamine. Expert Opin. Invest. Drugs, 2000, 9, 2393-2402.
-
(2000)
Expert Opin. Invest. Drugs
, vol.9
, pp. 2393-2402
-
-
Sramek, J.J.1
Frackiewicz, E.J.2
Cutler, N.R.3
-
61
-
-
63349094728
-
Galantamine inhibits β-amyloid aggregation and cytotoxicity
-
Matharu, B.; Gibson, G.; Parsons, R.; Huckerby, T.N.; Moore, S.A.; Cooper, L.J.; Millichamp, R.; Allsop, D.; Austen, B. Galantamine inhibits β-amyloid aggregation and cytotoxicity. J. Neurol. Sci., 2009, 280, 49-58.
-
(2009)
J. Neurol. Sci.
, vol.280
, pp. 49-58
-
-
Matharu, B.1
Gibson, G.2
Parsons, R.3
Huckerby, T.N.4
Moore, S.A.5
Cooper, L.J.6
Millichamp, R.7
Allsop, D.8
Austen, B.9
-
62
-
-
1042291157
-
The cognitive benefits of galantamine are sustained for at least 36 months: A long term extension trial
-
Raskind, M.A.; Peskind, E.R.; Truyen, L.; Kershaw, P.; Damaraju, C.V. The cognitive benefits of galantamine are sustained for at least 36 months: a long term extension trial. Arch. Neurol., 2004, 61, 252-256.
-
(2004)
Arch. Neurol.
, vol.61
, pp. 252-256
-
-
Raskind, M.A.1
Peskind, E.R.2
Truyen, L.3
Kershaw, P.4
Damaraju, C.V.5
-
63
-
-
37549067046
-
Combination of HSCCC and sephadex LH-20 methods. An approach to isolation and purification of the main individual theaflavins from black tea
-
Yang, C.; Li, D.; Wan, X. Combination of HSCCC and sephadex LH-20 methods. An approach to isolation and purification of the main individual theaflavins from black tea. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2008, 861, 140-144.
-
(2008)
Chromatogr. B: Anal. Technol. Biomed. Life Sci.
, vol.861
, pp. 140-144
-
-
Yang, C.1
Li, D.2
Wan, X.3
-
64
-
-
52649108151
-
New phenolic components and chromatographic profiles of green and fermented teas
-
Lin, L.Z.; Chen, P.; Harnly, J.M. New phenolic components and chromatographic profiles of green and fermented teas. J. Agric. Food Chem., 2008, 56, 8130-8140.
-
(2008)
J. Agric. Food Chem.
, vol.56
, pp. 8130-8140
-
-
Lin, L.Z.1
Chen, P.2
Harnly, J.M.3
-
65
-
-
82955194531
-
Black tea theaflavins inhibit formation of toxic amyloidβ and α-synuclein fibrils
-
Grelle, G.; Otto, A.; Lorenz, M.; Frank, R.F.; Wanker, E.E.; Bieschke, J, Black tea theaflavins inhibit formation of toxic amyloidβ and α-synuclein fibrils. Biochemistry, 2011, 50, 10624-10636.
-
(2011)
Biochemistry
, vol.50
, pp. 10624-10636
-
-
Grelle, G.1
Otto, A.2
Lorenz, M.3
Frank, R.F.4
Wanker, E.E.5
Bieschke, J.6
-
66
-
-
79955806884
-
Mutations that replace aromatic side chains promote aggregation of the Alzheimer's Aβ peptide
-
Armstrong, A.H.; Chen, J.; Angela Fortner McKoy, A.F.; Hecht, M.H. Mutations That Replace Aromatic Side Chains Promote Aggregation of the Alzheimer's Aβ Peptide. Biochemistry, 2011, 50(19), 4058-4067.
-
(2011)
Biochemistry
, vol.50
, Issue.19
, pp. 4058-4067
-
-
Armstrong, A.H.1
Chen, J.2
Angela Fortner McKoy, A.F.3
Hecht, M.H.4
-
67
-
-
34250220693
-
Estrogen has anti-amyloidogenic effects on Alzheimer's β-amyloid fibrils in vitro
-
Morinaga, A.; Hirohata, M.; Ono, K.; Yamada, M. Estrogen has anti-amyloidogenic effects on Alzheimer's β-amyloid fibrils in vitro. Biochem. Biophys. Resh. Comm., 2007, 359, 697-702.
-
(2007)
Biochem. Biophys. Resh. Comm.
, vol.359
, pp. 697-702
-
-
Morinaga, A.1
Hirohata, M.2
Ono, K.3
Yamada, M.4
-
68
-
-
0030030956
-
First-order kinetic model of Alzheimer's β amyloid fibril extension in vitro
-
Naiki, H.; Nakakuki, K. First-order kinetic model of Alzheimer's β amyloid fibril extension in vitro. Lab. Invest., 1996, 74, 374-383.
-
(1996)
Lab. Invest.
, vol.74
, pp. 374-383
-
-
Naiki, H.1
Nakakuki, K.2
-
69
-
-
30044438885
-
Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model
-
Yue, X.; Lu, M.; Lancaster, T.; Cao, P.; Honda, S.; Staufenbiel, M.; Harada, N.; Zhong, Z.; Shen, Y.; Li, R. Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U.S.A., 2005, 102, 19198-19203.
-
(2005)
Proc. Natl. Acad. Sci. U.S.A.
, vol.102
, pp. 19198-19203
-
-
Yue, X.1
Lu, M.2
Lancaster, T.3
Cao, P.4
Honda, S.5
Staufenbiel, M.6
Harada, N.7
Zhong, Z.8
Shen, Y.9
Li, R.10
-
70
-
-
78649634550
-
Alpha-tocopherol quinone inhibits β-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines
-
Yang, S.; Wang, W.; Ling, T.; Feng, Y.; Du, X.; Zhang, X.; Sun, X.; Zhao, M.; Xue, D.; Yang, Y.; Liu, R. Alpha-tocopherol quinone inhibits β-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines. Neurochem. Int., 2010, 57, 914-922.
-
(2010)
Neurochem. Int.
, vol.57
, pp. 914-922
-
-
Yang, S.1
Wang, W.2
Ling, T.3
Feng, Y.4
Du, X.5
Zhang, X.6
Sun, X.7
Zhao, M.8
Xue, D.9
Yang, Y.10
Liu, R.11
-
71
-
-
18844444191
-
Role of glutathione in intracellular amyloidβalpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity
-
Woltjer, R.L.; Nghiem, W.; Maezawa, I.; Milatovic, D.; Vaisar, T.; Montine, K.S.; Montine, T.J. Role of glutathione in intracellular amyloidβalpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J. Neurochem., 2005, 93, 1047-1056.
-
(2005)
J. Neurochem.
, vol.93
, pp. 1047-1056
-
-
Woltjer, R.L.1
Nghiem, W.2
Maezawa, I.3
Milatovic, D.4
Vaisar, T.5
Montine, K.S.6
Montine, T.J.7
-
72
-
-
0033788416
-
Vitamin E prevents Alzheimer's amyloid β-peptide (1-42) induced neuronal protein oxidation and reactive oxygen species production
-
Yatin, S.M.; Varadarajan, S.; Butterfield, D.A. Vitamin E prevents Alzheimer's amyloid β-peptide (1-42) induced neuronal protein oxidation and reactive oxygen species production. J. Alzheimers Dis., 2000, 2, 123-131.
-
(2000)
J. Alzheimers Dis.
, vol.2
, pp. 123-131
-
-
Yatin, S.M.1
Varadarajan, S.2
Butterfield, D.A.3
-
73
-
-
0034718206
-
Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization
-
Findeis, M.A. Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization. Biochim. Biophys. Acta, 2000, 1502, 76-84.
-
(2000)
Biochim. Biophys. Acta
, vol.1502
, pp. 76-84
-
-
Findeis, M.A.1
-
74
-
-
1642453817
-
Both the D- (+) and L-(-) enantiomers of nicotine inhibit Aβ aggregation and cytotoxicity
-
Moore, S.A.; Huckerby, T.N.; Gibson, G.L.; Fullwood, N.J.; Turnbull, S.; Tabner, B.J.; El- Agnaf, O.M.A.; Allsop, D. Both the D- (+) and L-(-) enantiomers of nicotine inhibit Aβ aggregation and cytotoxicity. Biochemistry, 2004, 43, 819-826.
-
(2004)
Biochemistry
, vol.43
, pp. 819-826
-
-
Moore, S.A.1
Huckerby, T.N.2
Gibson, G.L.3
Fullwood, N.J.4
Turnbull, S.5
Tabner, B.J.6
El- Agnaf, O.M.A.7
Allsop, D.8
-
75
-
-
0029956783
-
Nicotine inhibits amyloid formation by the β-peptide
-
Salomon, A.R.; Marcinowski, K.J.; Friedland, R.P.; Zagorski, M.G. Nicotine inhibits amyloid formation by the β-peptide. Biochemistry, 1996, 35, 13568-13578.
-
(1996)
Biochemistry
, vol.35
, pp. 13568-13578
-
-
Salomon, A.R.1
Marcinowski, K.J.2
Friedland, R.P.3
Zagorski, M.G.4
-
76
-
-
0035251678
-
Nicotine and amyloid formation
-
Zeng, H.; Zhang, Y.; Peng, L.; Shao, H.; Menon, N.K.; Yang, J.; Salomon, A.R.; Freidland, R.P.; Zagorski, M.G. Nicotine and amyloid formation. Biol. Psychiatry, 2001, 49, 248-257.
-
(2001)
Biol. Psychiatry
, vol.49
, pp. 248-257
-
-
Zeng, H.1
Zhang, Y.2
Peng, L.3
Shao, H.4
Menon, N.K.5
Yang, J.6
Salomon, A.R.7
Freidland, R.P.8
Zagorski, M.G.9
-
77
-
-
0030880424
-
Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine
-
Kim, S.H.; Kim, Y.K.; Jeong, S.J.; Haass, C.; Kim, Y.H.; Suh, Y.H. Enhanced release of secreted form of Alzheimer's amyloid precursor protein from PC12 cells by nicotine. Mol. Pharmacol., 1997, 52, 430-436.
-
(1997)
Mol. Pharmacol.
, vol.52
, pp. 430-436
-
-
Kim, S.H.1
Kim, Y.K.2
Jeong, S.J.3
Haass, C.4
Kim, Y.H.5
Suh, Y.H.6
-
78
-
-
0343570105
-
Modulation of β-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors
-
Lindahl, H.E. Modulation of β-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors. Eur. J. Pharmacol., 2000, 393, 255-263.
-
(2000)
Eur. J. Pharmacol.
, vol.393
, pp. 255-263
-
-
Lindahl, H.E.1
-
79
-
-
0035251766
-
Effects of nicotine on APP secretion and Abeta- or CT (105)-induced toxicity
-
Seo, J.; Kim, S.; Kim, H.; Park, C.H.; Jeong, S.; Lee, J.; Choi, S.H.; Chang, K.; Rah, J.; Koo, J.; Kim, E.; Suh, Y. Effects of nicotine on APP secretion and Abeta- or CT (105)-induced toxicity. Biol. Psychiatry, 2001, 49, 240-247.
-
(2001)
Biol. Psychiatry
, vol.49
, pp. 240-247
-
-
Seo, J.1
Kim, S.2
Kim, H.3
Park, C.H.4
Jeong, S.5
Lee, J.6
Choi, S.H.7
Chang, K.8
Rah, J.9
Koo, J.10
Kim, E.11
Suh, Y.12
-
80
-
-
0032994040
-
In vitro and in vivo studies investigating possible antioxidant actions of nicotine: Relevance to Parkinson's and Alzheimer's diseases
-
Linert, W.; Bridge, M.H.; Huber, M.; Bjugstad, K.B.; Grossman, S.; Arendash.; G.W. In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases. Biochim. Biophys. Acta, 1999, 1454, 143-152.
-
(1999)
Biochim. Biophys. Acta
, vol.1454
, pp. 143-152
-
-
Linert, W.1
Bridge, M.H.2
Huber, M.3
Bjugstad, K.B.4
Grossman, S.5
Arendash, G.W.6
-
81
-
-
0036316642
-
Chronic nicotine treatment reduces β-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)
-
Nordberg, A.; Lindahl, H.E.; Lee, M.; Johnson, M.; Mousavi, M.; Hall, R.; Perry, E.; Bednar, I.; Court, J. Chronic nicotine treatment reduces β-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J. Neurochem., 2002, 81, 655-658.
-
(2002)
J. Neurochem.
, vol.81
, pp. 655-658
-
-
Nordberg, A.1
Lindahl, H.E.2
Lee, M.3
Johnson, M.4
Mousavi, M.5
Hall, R.6
Perry, E.7
Bednar, I.8
Court, J.9
-
82
-
-
0026688245
-
Antioxidant potential of ferulic acid
-
Graf, E. Antioxidant potential of ferulic acid. Free Radic. Biol. Med., 1992, 13, 435-448.
-
(1992)
Free Radic. Biol. Med.
, vol.13
, pp. 435-448
-
-
Graf, E.1
-
83
-
-
0027521574
-
Evaluation of the antioxidant actions of ferulic acid and catechins
-
Scott, B.C.; Butler, J.; Halliwell, B.; Aruoma, O.I. Evaluation of the antioxidant actions of ferulic acid and catechins. Free Radic. Res. Commun., 1993, 19, 241-253.
-
(1993)
Free Radic. Res. Commun.
, vol.19
, pp. 241-253
-
-
Scott, B.C.1
Butler, J.2
Halliwell, B.3
Aruoma, O.I.4
-
84
-
-
13644265462
-
Ferulic acid ethyl ester protects neurons against amyloidβ-peptide (1-42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity
-
Sultana, R.; Ravagna, A.; Mohmmad-Abdul, H.; Calabrese, V.; Butterfield, D.A. Ferulic acid ethyl ester protects neurons against amyloidβ-peptide (1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem., 2005, 92, 749-758.
-
(2005)
J. Neurochem.
, vol.92
, pp. 749-758
-
-
Sultana, R.1
Ravagna, A.2
Mohmmad-Abdul, H.3
Calabrese, V.4
Butterfield, D.A.5
-
85
-
-
24644438783
-
Ferulic acid destabilizes preformed β-amyloid fibrils in vitro
-
Ono, K.; Hirohata, M.; Yamada, M. Ferulic acid destabilizes preformed β-amyloid fibrils in vitro. Biochem. Biophys. Res. Comm., 2005, 336, 444-449.
-
(2005)
Biochem. Biophys. Res. Comm.
, vol.336
, pp. 444-449
-
-
Ono, K.1
Hirohata, M.2
Yamada, M.3
-
86
-
-
79955406741
-
A-40 and A-42 amyloid fibrils exhibit distinct molecular properties
-
Sanchez, L.; Madurga, S.; Pukala, T.; Vilaseca, M.; Lopez-Iglesias, C.; Robinson, C.V.; Giralt, E.; Carulla, N. A-40 and A-42 amyloid fibrils exhibit distinct molecular properties. J. Am. Chem. Soc., 2011, 133, 6505-6508.
-
(2011)
J. Am. Chem. Soc.
, vol.133
, pp. 6505-6508
-
-
Sanchez, L.1
Madurga, S.2
Pukala, T.3
Vilaseca, M.4
Lopez-Iglesias, C.5
Robinson, C.V.6
Giralt, E.7
Carulla, N.8
-
87
-
-
84921911946
-
Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus
-
Mirza, Z.; Ali, A.; Ashraf, G.M.; Kamal, M.A.; Abuzenadah, A.M.; Choudhary, A.G.A.; Damanhouri, G.A.; Sheikh, I.A. Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus. CNS Neurol. Disord. Drug Targets, 2013, (DOI: 10.2174/18715273113126660144)
-
(2013)
CNS Neurol. Disord. Drug Targets
-
-
Mirza, Z.1
Ali, A.2
Ashraf, G.M.3
Kamal, M.A.4
Abuzenadah, A.M.5
Choudhary, A.G.A.6
Damanhouri, G.A.7
Sheikh, I.A.8
-
88
-
-
77953265026
-
Targeting the brain-surmounting or bypassing the blood brain barrier
-
Potschka, H. Targeting the brain-surmounting or bypassing the blood brain barrier. Handb. Exp. Pharmacol., 2010, 197, 411-431.
-
(2010)
Handb. Exp. Pharmacol.
, vol.197
, pp. 411-431
-
-
Potschka, H.1
-
89
-
-
84870333528
-
Nanotechnology-based approaches in anticancer research
-
Jabir, N.R.; Tabrez, S.; Ashraf, G.M.; Shakil, S.; Damanhouri, G.A.; Kamal, M, A. Nanotechnology-based approaches in anticancer research. Int. J. Nanomed., 2012, 7, 4391-4408.
-
(2012)
Int. J. Nanomed.
, vol.7
, pp. 4391-4408
-
-
Jabir, N.R.1
Tabrez, S.2
Ashraf, G.M.3
Shakil, S.4
Damanhouri, G.A.5
Kamal, M.A.6
-
90
-
-
79956156448
-
Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: Functional similarities with proteins
-
Seong, I.Y.; Ming, Y.; Jeffrey, R.B.; Vivekanandan, S.; Kai, S.; Nam, E.J.; Soo-Hwan, J.; Ayyalusamy, R.; Nicholas, A.K. Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: Functional similarities with proteins. Angew. Chem. Int. Ed., 2011, 50, 5110-5115.
-
(2011)
Angew. Chem. Int. Ed.
, vol.50
, pp. 5110-5115
-
-
Seong, I.Y.1
Ming, Y.2
Jeffrey, R.B.3
Vivekanandan, S.4
Kai, S.5
Nam, E.J.6
Soo-Hwan, J.7
Ayyalusamy, R.8
Nicholas, A.K.9
-
91
-
-
6344258939
-
Drug delivery to the brain-realization by novel drug carriers
-
Muller, R.H.; Keck, C.M. Drug delivery to the brain-realization by novel drug carriers. J. Nanosci. Nanotechnol., 2004, 4, 471-483.
-
(2004)
J. Nanosci. Nanotechnol.
, vol.4
, pp. 471-483
-
-
Muller, R.H.1
Keck, C.M.2
-
92
-
-
26944467652
-
Polymer hollow particles with controllable holes in their surfaces
-
Hyuk, I.M.S.; Jeong, U.; Xia, Y, Polymer hollow particles with controllable holes in their surfaces. Nat. Mater., 2005, 4, 671-675.
-
(2005)
Nat. Mater.
, vol.4
, pp. 671-675
-
-
Hyuk, I.M.S.1
Jeong, U.2
Xia, Y.3
-
93
-
-
33748175137
-
Bronich. TK Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs
-
Bontha, S.; Kabanov, A.V.; Bronich. TK Polymer micelles with cross-linked ionic cores for delivery of anticancer drugs. J. Control. Release, 2006, 114, 163-174.
-
(2006)
J. Control. Release
, vol.114
, pp. 163-174
-
-
Bontha, S.1
Kabanov, A.V.2
-
94
-
-
34547601983
-
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders
-
Kabanov, A.V.; Gendelman, H.E. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci., 2007, 32(8-9): 1054-1082.
-
(2007)
Prog. Polym. Sci.
, vol.32
, Issue.8-9
, pp. 1054-1082
-
-
Kabanov, A.V.1
Gendelman, H.E.2
-
95
-
-
34548236292
-
Endosomal release and intracellular delivery of anticancer drugs using pH-sensitive pegylated nanogels
-
Oishi, M.; Hayashi, H.; Iijima, M.; Nagasaki, Y. Endosomal release and intracellular delivery of anticancer drugs using pH-sensitive pegylated nanogels. J. Mater. Chem., 2007, 17, 3720-3725.
-
(2007)
J. Mater. Chem.
, vol.17
, pp. 3720-3725
-
-
Oishi, M.1
Hayashi, H.2
Iijima, M.3
Nagasaki, Y.4
-
96
-
-
84887891918
-
Implication of the nutritional and non- nutritional factors in the context of preservation of cognitive performance in demented/ depressed and Alzheimer patients
-
Aliev, G.; Ashraf, G.M.; Kaminsky, Y.G.; Sheikh, I.A.; Sudakov, K.V.; Bachurin, S.O. Implication of the Nutritional and Non- Nutritional Factors in the Context of Preservation of Cognitive Performance in Demented/ Depressed and Alzheimer Patients. Am. J. Alzheimers Dis. Other Demen., 2013. (DOI: 10.1177/ 1533317513504614)
-
(2013)
Am. J. Alzheimers Dis. Other Demen.
-
-
Aliev, G.1
Ashraf, G.M.2
Kaminsky, Y.G.3
Sheikh, I.A.4
Sudakov, K.V.5
Bachurin, S.O.6
-
97
-
-
84896700209
-
Age-Related Defects in Erythrocyte 2, 3-Diphosphoglycerate Metabolism in Dementia
-
Kaminsky, Y.G.; Reddy, V.P.; Ashraf, G.M.; Ahmad, A.; Benberin, V.V.; Kosenko, E.A.; Aliev, G. Age-Related Defects in Erythrocyte 2, 3-Diphosphoglycerate Metabolism in Dementia. Aging Dis., 2013, 4(5), 244-255.
-
(2013)
Aging Dis.
, vol.4
, Issue.5
, pp. 244-255
-
-
Kaminsky, Y.G.1
Reddy, V.P.2
Ashraf, G.M.3
Ahmad, A.4
Benberin, V.V.5
Kosenko, E.A.6
Aliev, G.7
-
98
-
-
33746377894
-
Protein misfolding, functional amyloid and human disease
-
Chiti, F.; Dobson, C.M. Protein misfolding, functional amyloid and human disease. Annu. Rev. Biochem., 2006, 75, 333-336.
-
(2006)
Annu. Rev. Biochem.
, vol.75
, pp. 333-336
-
-
Chiti, F.1
Dobson, C.M.2
-
99
-
-
84864273268
-
PEGylated nanoparticles bind to and alter amyloidβ- peptide conformation: Towards engineering of functional nanomedicines for Alzheimer's disease
-
Davide, B.; Romain, V.; Benjamin, L.D.; Julien, N.; Myriam, T.; Juraj. K.; Barbara, L.; Line, D.K.; Mara, C.; Marco, G.; Valerie, N.; Wiep, S.; Moein, S.M.; Igor, T.S.; Patrick, C.; Karine, A. PEGylated nanoparticles bind to and alter amyloidβ- peptide conformation: Towards engineering of functional nanomedicines for Alzheimer's disease. ACS Nano, 2012, 6, 5897-5908.
-
(2012)
ACS Nano
, vol.6
, pp. 5897-5908
-
-
Davide, B.1
Romain, V.2
Benjamin, L.D.3
Julien, N.4
Myriam, T.5
Juraj, K.6
Barbara, L.7
Line, D.K.8
Mara, C.9
Marco, G.10
Valerie, N.11
Wiep, S.12
Moein, S.M.13
Igor, T.S.14
Patrick, C.15
Karine, A.16
-
100
-
-
84870351750
-
Indomethacinloaded lipid-core nanocapsules reduce the damage triggered by A- 1-42 in Alzheimer's disease models
-
Andressa, B.; Rudimar, L.F.; André, M.; Juliana, B.H.; Ana Maria, O.B.; Adriana, R.P.; Sílvia, S.G.; Christianne, G.S. Indomethacinloaded lipid-core nanocapsules reduce the damage triggered by A- 1-42 in Alzheimer's disease models. International J. Nanomed., 2012, 7, 4927-4942.
-
(2012)
International J. Nanomed.
, vol.7
, pp. 4927-4942
-
-
Andressa, B.1
Rudimar, L.F.2
André, M.3
Juliana, B.H.4
Ana Maria, O.B.5
Adriana, R.P.6
Sílvia, S.G.7
Christianne, G.S.8
-
101
-
-
84880062949
-
Gold nanospheres as inhibitors of amyloidβ- protein aggregation involved in Alzheimer's disease
-
Mihyun, L.; Deborah, S.O.; Rahina, M.; Melissa, A.M. Gold nanospheres as inhibitors of amyloidβ- protein aggregation involved in Alzheimer's disease. J. S. C. Acad. Sci., 2011, 9, 14-17.
-
(2011)
J. S. C. Acad. Sci.
, vol.9
, pp. 14-17
-
-
Mihyun, L.1
Deborah, S.O.2
Rahina, M.3
Melissa, A.M.4
-
102
-
-
80051800071
-
Multivitamin-mineral and vitamins (E+C) supplementation modulate chronic unpredictable stress induced oxidative damage in brain and heart of mice
-
Hasan, S.; Bilal, N.; Naqvi, S.; Ashraf, G.M.; Suhail. N.; Sharma, S.; Banu, N. Multivitamin-mineral and vitamins (E+C) supplementation modulate chronic unpredictable stress induced oxidative damage in brain and heart of mice. Biol. Trace Elem. Res., 2011, 142(3), 589-597.
-
(2011)
Biol. Trace Elem. Res.
, vol.142
, Issue.3
, pp. 589-597
-
-
Hasan, S.1
Bilal, N.2
Naqvi, S.3
Ashraf, G.M.4
Suhail, N.5
Sharma, S.6
Banu, N.7
-
103
-
-
84860470430
-
Brain region specific monoamine and oxidative changes during restraint stress
-
Ahmad, A.; Rasheed, N.; Ashraf, G.M.; Kumar, R.; Banu, N.; Khan, F.; Al-Sheeh, M, Palit, G. Brain region specific monoamine and oxidative changes during restraint stress. Can. J. Neurol. Sci., 2012, 39(3), 311-318.
-
(2012)
Can. J. Neurol. Sci.
, vol.39
, Issue.3
, pp. 311-318
-
-
Ahmad, A.1
Rasheed, N.2
Ashraf, G.M.3
Kumar, R.4
Banu, N.5
Khan, F.6
Al-Sheeh, M.7
Palit, G.8
-
104
-
-
84862825882
-
Novel Ocimumoside A and B as anti-stress agents: Modulation of brain monoamines and antioxidant systems in chronic unpredictable stress model in rats
-
Ahmad, A.; Rasheed, N.; Gupta, P.; Singh, S.; Siripurapu, K.B.; Ashraf, G.M.; Kumar, R.; Chand, K.; Maurya, R.; Banu, N.; Alsheeha, M.; Palit, G. Novel Ocimumoside A and B as anti-stress agents: Modulation of brain monoamines and antioxidant systems in chronic unpredictable stress model in rats. Phytomedicine, 2012, 19, 639-647.
-
(2012)
Phytomedicine
, vol.19
, pp. 639-647
-
-
Ahmad, A.1
Rasheed, N.2
Gupta, P.3
Singh, S.4
Siripurapu, K.B.5
Ashraf, G.M.6
Kumar, R.7
Chand, K.8
Maurya, R.9
Banu, N.10
Alsheeha, M.11
Palit, G.12
-
105
-
-
84904470892
-
Nanotechnological approach in management of Alzheimer's diseases and type 2 diabetes
-
Article in press
-
Alam, Q.; Haque, A.; Alam, M.Z.; Karim, S.; Kamal, M.A. Jiman- Fatani, A.; Damanhouri, G.A.; Abuzenadah, A.M.; Chaudhary, A.G.A. Nanotechnological approach in management of Alzheimer's diseases and type 2 diabetes. CNS Neurol. Disord. Drug Targets, 2013, Article in press, (DOI: 10.2174/18715273113126660159).
-
(2013)
CNS Neurol. Disord. Drug Targets
-
-
Alam, Q.1
Haque, A.2
Alam, M.Z.3
Karim, S.4
Kamal, M.A.5
Jiman-Fatani, A.6
Damanhouri, G.A.7
Abuzenadah, A.M.8
Chaudhary, A.G.A.9
-
106
-
-
84884536019
-
Nanoneurotoxicity to nanoneuroprotection using biological & computational approaches
-
Iqbal, A.; Ahmad, I.; Khalid, M.H.; Nawaz M.S.; Siew Hua Gan, S.H.; Kamal, M.A. Nanoneurotoxicity to nanoneuroprotection using biological & computational approaches. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 2013, 31, 256-284.
-
(2013)
J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev.
, vol.31
, pp. 256-284
-
-
Iqbal, A.1
Ahmad, I.2
Khalid, M.H.3
Nawaz, M.S.4
Siew Hua Gan, S.H.5
Kamal, M.A.6
|